FDA approves Purdue Pharma’s Palladone
hydrochloride) capsules for the management of persistent moderate
to severe pain in patients requiring continuous opioid pain
relief for an extended period of time.
The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union
Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.
Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.